Evidence map›Paper›PMID 30380660›Full record

ArticleBiomolecules2018

pH-Sensitive Co-Adsorption/Release of Doxorubicin and Paclitaxel by Carbon Nanotube, Fullerene, and Graphene Oxide in Combination with

Milad Rezaian, Reza Maleki, Mohammad Dahri Dahroud, Abdolmohammad Alamdari, Milad Alimohammadi

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Synthesis, Characterization, Cellular Uptake, andFrontiers in pharmacology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Milad RezaianDepartment of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, 19839-63113 Tehran, Iran. m.rezaian@sbmu.ac.ir.
Reza MalekiDepartment of Chemical Engineering, School of Chemical and Petroleum Engineering, Shiraz University, Shiraz 71345, Iran. r.maleki@shirazu.ac.ir.
Mohammad Dahri DahroudStudent Research Committee, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz 71345, Iran. stud1361866594@sums.ac.ir.
Abdolmohammad AlamdariDepartment of Chemical Engineering, School of Chemical and Petroleum Engineering, Shiraz University, Shiraz 71345, Iran. alamdari44@yahoo.com.
Milad AlimohammadiDepartment of Chemical Engineering, Azad University, Kermanshah, Iran. rayanghasr@yahoo.com.
Shiraz University · IRIslamic Azad University of Kermanshah · IRShahid Beheshti University of Medical Sciences · IRShiraz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanotechnology based drug delivery systems for cancer therapy have been the topic of interest for many researchers and scientists. In this research, we have studied the pH sensitive co-adsorption and release of doxorubicin (DOX) and paclitaxel (PAX) by carbon nanotube (CNT), fullerene, and graphene oxide (GO) in combination with

Indexed as

Drug LiberationMolecular Dynamics SimulationAcrylamidesAdsorptionDoxorubicinDrug CarriersFullerenesGraphiteHydrogen BondingHydrogen-Ion ConcentrationNanotubes, CarbonPaclitaxelStatic ElectricityThermodynamicsAcrylamidesDoxorubicinDrug CarriersFullerenesgraphene oxideGraphiteNanotubes, CarbonN-isopropylacrylamidePaclitaxeldoxorubicinfullerenegraphene oxideloadingmolecular dynamicsnanotubeN-isopropylacrylamidepaclitaxelrelease

Identifiers

PMID30380660
PMCPMC6316683
OpenAlexW2898981055

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.